Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective Apo-B100

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 1084-1093

  Borén, Jan ^a,c   Lee, Isabelle ^a   Zhu, Weimin ^a   Arnold, Kay ^a   Taylor, Stacy ^a   Innerarity, Thomas L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Familial defective apo B100; LDL receptor; Lipoproteins; Receptor binding; Transgenic mice

Indexed keywords

APOLIPOPROTEIN B100; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BINDING COMPETITION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING;

EID: 0032030919     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1847     Document Type: Article

References (33)

1. Goldstein, J.L., M.S. Brown, R.G.W. Anderson, D.W. Russell, and W.J. Schneider. 1985. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol. 1:1-39.
2. Innerarity, T.L., R.W. Mahley, K.H. Weisgraber, T.P. Bersot, R.M. Krauss, G.L. Vega, S.M. Grundy, W. Friedl, J. Davignon, and B.J. McCarthy. 1990. Familial detective apolipoprotein B100: a mutation of apolipoprotein B that causes hypercholesterolemia. J. Lipid Res. 31:1337-1349.
3. Hobbs, H.H., M.S. Brown, and J.L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
4. Innerarity, T.L., K.H. Weisgraber, K.S. Arnold, R.W. Mahley, R.M. Krauss, G.L. Vega, and S.M. Grundy. 1987. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84:6919-6923.
5. Gaffney, D., J.M. Reid, I.M. Cameron, K. Vass, M.J. Caslake, J. Shepherd, and C.J. Packard. 1995. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15:1025-1029.
6. Pullinger, C.R., L.K. Hennessy, J.E. Chatterton, W. Liu, J.A. Love, C.M. Mendel, P.H. Frost, M.J. Malloy, V.N. Schumaker, and J.P. Kane. 1995. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 95:1225-1234.
7. Milne, R., R. Théolis, Jr., R. Maurice, R.J. Pease, P.K. Weech, E. Rassart, J.-C. Fruchart, J. Scott, and Y.L. Marcel. 1989. The use of monoclonal antihodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J. Biol. Chem. 264:19754-19760.
8. Welty, F.K., L. Seman, and F.T. Yen. 1995. Purification of the apolipoprotein B-67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor. J. Lipid Res. 36:2622-2629.
9. Parhofer, K.G., A. Daugherty, M. Kinoshita, and G. Schonfeld. 1990. Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB-89. J. Lipid Res. 31:2001-2007.
10. Krul, E.S., K.G. Parhofer, P.H.R. Barrett, R.D. Wagner, and G. Schonfeld. 1992. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J. Lipid Res. 33:1037-1050.
11. Mahley, R.W., T.L. Innerarity. R.E. Pitas, K.H. Weisgraber, J.H. Brown, and E. Gross. 1977. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J. Biol. Chem. 252:7279-7287.
12. Weisgraber, K.H., T.L. Innerarity, and R.W. Mahley. 1978. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253:9053-9062.
13. Knott, T.J., S.C. Rall, Jr., T.L. Innerarity, S.F. Jacobson, M.S. Urdea, B. Levy-Wilson, L.M. Powell, R.J. Pease, R. Eddy, H. Nakai. et al. 1985. Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science. 230:37-43.
14. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:622-630.
15. Linton, M.F., R.V. Farese, Jr., G. Chiesa, D.S. Grass, P. Chin, R.E. Hammer, H.H. Hobbs, and S.G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92:3029-3037.
16. Borén, J., I. Lee, M.J. Callow, E.M. Rubin, and T.L. Innerarity. 1996. A simple and efficient method for making site-directed mutants, deletions, and fusions of large DNA such as P1 and BAC clones. Genome Res. 6:1123-1130.
17. Yao, Z., B.D. Blackhart, D.F. Johnson, S.M. Taylor, K.W. Haubold, and B.J. McCarthy. 1992. Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. J. Biol. Chem. 267:1175-1182.
18. McCormick, S.P.A., M.F. Linton, and S.G. Young. 1994. Expression of P1 DNA in mammalian cells and transgenic mice. Genet. Anal. Tech. Appl. 11: 158-164.
19. Arnold, K.S., T.L. Innerarity, R.E. Pitas, and R.W. Mahley. 1992. Lipoprotein-receptor interactions. In Lipoprotein Analysis. A Practical Approach. C.A. Converse, and E.R. Skinner, editors. Oxford University Press, Oxford. 145-168.
20. Weisgraber, K.H., T.L. Innerarity, Y.M. Newhouse, S.G. Young, K.S. Arnold, R.M. Krauss, G.L. Vega, S.M. Grundy, and R.W. Mahley. 1988. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc. Natl. Acad. Sci. USA. 85: 9758-9762.
21. Forte, T.M., and R.W. Nordhausen. 1986. Electron microscopy of negntively stained lipoproteins. Methods Enzymol. 128:442-457.
22. Milne, R.W., R. Theolis, Jr., R.B. Verdery, and Y.L. Marcel. 1983. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 3:23-30.
23. Young, S.G., R.K. Koduri, R.K. Austin, D.J. Bonnet, R.S. Smith. and L.K. Curtiss. 1994. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody. MB47. J. Lipid Res. 35: 399-407.
24. Farese, R.V., Jr., M.M. Véniant, C.M. Cham, L.M. Flynn, V. Pierotti, J.F. Loring, M. Traber, S. Ruland, R.S. Stokowski, D. Huszar, and S.G. Young. 1996. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc. Natl. Acad. Sci. USA. 93:6393-6398.
25. Borchardt, R.A., and R.A. Davis. 1987. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J. Biol. Chem. 262:16394-16402.
26. Chiesa, G., D.F. Johnson, Z. Yao, T.L. Innerarity, R.W. Mahley, S.G. Young, R.H. Hammer, and H.H. Hobbs. 1993. Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA. J. Biol. Chem. 268:23747-23750.
27. Law, A., and J. Scott. 1990. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. J. Lipid Res. 31:1109-1120.
28. Weisgraber, K.H., and S.C. Rall. Jr. 1987. Human apolipoprolein B-100 heparin-binding sites. J. Biol. Chem. 262:11097-11103.
29. Chatterton, J.E., M.L. Phillips, L.K. Curtiss, R. Milne, J.-C. Fruchart, and V.N. Schumaker. 1995. Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. J. Lipid Res. 36:2027-2037.
30. 13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. J. Biol. Chem. 266:2701-2704.
31. McCormick, S.P.A., J.K. Ng, M. Véniant, J. Borén, V. Pierotti, L.M. Flynn, D.S. Grass, A. Connolly, and S.G. Young. 1996. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene. J. Biol. Chem. 271:11963-11970.
32. Kleinman, Y., G. Schonfeld, D. Gavish, Y. Oschry, and S. Eisenberg. 1987. Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients. J. Lipid Res. 28:540-548.
33. Avriam, M., S. Lund-Katz, M.C. Phillips, and A. Chait. 1988. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J. Biol. Chem. 263:16842-16848.